Molecular detection and characterization of Merkle Cell Polyoma virus in Lymphomas among Sudanese patients

Yıl 2020, , 47 - 51, 15.03.2020

Mohammed A Ibrahim Khalid A Enan Abdel Rahim M El Hussein Mohamed O. Mustafa Bashir Salim Isam M Elkhidir

https://doi.org/10.5799/jmid.700515

Öz

Objectives: Lymphoma (Hodgkin and Non-Hodgkin) is one of the most common malignancies in Sudan. Contemporaneous studies from several countries including the United States, Japan and Germany suggested a possible etiological link between Merkle cell polyoma virus (MCPyV) and these lymphomas; however, there are no previous studies that have been reported on this topic in Sudan. This study was applied to investigate the role of this virus in lymphoma patients in Sudan. Objective is to detect and characterize Merkle Cell Polyomavirus in lymphoma patients by using molecular techniques
Method: Adult Sudanese patients (both females and males) diagnosed with lymphoma were included in this study. Blood samples were used for DNA extraction which was then subjected to Real-time PCR to detect MCPyV DNA. Samples, proved positive by Real-time PCR amplification, were sequenced and phylogenetically analyzed.
Results: MCPyV was detected in 16/225 from Sudanese (7.1%) of lymphoma patients of which five were Hodgkin and eleven were Non-Hodgkin. MCPyV sequences in Sudanese patients showed 100% similarity to each other and 100% identity with reference sequences from gene bank.
Conclusion: This study is the first evidence that MCPyV exists in a subset of Sudanese lymphoma patients. MCPyV is unlikely to have direct contribution in the pathogenesis of lymphoma in the majority of Sudanese cases. MCPyV identified from the Sudanese lymphoma subjects may constitute an African lineage and its pathogenicity needs to be investigated in future studies. J Microbiol Infect Dis 2020; 10(1):47-52.

Anahtar Kelimeler

Merkle Cell Polyomavirus, Hodgkin Lymphoma, Non-Hodgkin, Real-time PCR, Sudan

Kaynakça

• 1. Tamura K, Sawada H, Izumi Y, et al, Kyushu Hematology Organization for Treatment (K-HOT) Study Group: Chronic Lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Haematol 2001, 67:152-157. 2. Gjoerup O, Chang Y: Update on human polyomaviruses and cancer. Adv Cancer Res 2010, 106:1–51. 3. Moens U, Ludvigsen M, Van Ghelue M. Human polyomaviruses in skin diseases. Patholog Res Int 2011; 123491:12. 4. Feng H, Shuda M, Chang Y, Moore PS: Clonal integration of a polyomavirus in human Merkle cell carcinoma. Science 2008, 319:1096–1100. 5. Scuda N, Hofmann J, Calvignac-Spencer S, et al. A novel human polyomavirus closely related to the African green monkey-derived lymphotropic polyomavirus. J Virol 2011, 85:4586–4590. 6. Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB. Merkle cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010, 7:509–515. 7. ZurHausen A: Opening new roads for MCPyV. Blood 2011, 117:6975–6976 8. Shuda M, Arora R, Kwun HJ, et al. Human Merkle cell polyomavirus infection I. MCV T antigen expression in Merkle cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 2009, 125:1243–1249. 9. Tolstov YL, Arora R, Scudiere SC, et al. Lack of evidence for direct involvement of Merkle cell polyomavirus (MCV) in chronic lymphocytic leukemia (CLL). Blood 2010, 115:4973-4974. 10. Toracchio S, Foyle A, Sroller V, et al. Lymphotropism of Merkle cell polyomavirus infection, Nova Scotia, Canada. Emerg Infect Dis 2010, 16:1702–1709. 11. Pantulu ND, Pallasch CP, Kurz AK, et al. Detection of a novel truncating Merkle cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells. Blood 2010, 116:5280–5284. 12. Haugg AM, Speel EJ, Pantulu ND, et al. Fluorescence in situ hybridization confirms the presence of Merkle cell polyomavirus in chronic lymphocytic leukemia cells. Blood 2011, 117:5776–5777. 13. Carter JJ, Paulson KG, Wipf GC, et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101:1510–1522. 14. Faust H, Pastrana DV, Buck CB, Dillner J, Ekström J. Antibodies to Merkel cell polyomavirus correlate to presence of viral DNA in the skin. J Infect Dis 2011; 203:1096–1100. 15. Viscidi RP, Rollison DE, Sondak VK, et al. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 2011; 18:1737–1743. 16. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. :Seroepidemiology of the human polyomaviruses. J Gen Virol 2003; 84: 1499–1504. 17. Touze A, Gaitan J, Arnold F, et al. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J ClinMicrobiol 2010; 48:1767–1770. 18. Nicol JT, Robinot R, Carpentier A, et al. Age-specific seroprevalences of Merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and Trichodysplasia spinulosa-associated polyomavirus. Clin Vaccine Immunol 2013; 20:363–368. 19. Goh S, Lindau C, Tiveljung-Lindell A, Allander T: Merkel cell polyomavirus in respiratory tract secretions. Emerg Infect Dis 2009; 15: 489–491. 20. Lam WY, Leung BW, Chu IM, et al. Survey for the presence of BK, JC, KI, WU and Merkel cell polyomaviruses inhuman brain tissues. J ClinVirol 2010; 48:11–14. 21. Kean JM, Rao S, Wang M, Garcea RL (March 2009). Atwood WJ (ed.), "Seroepidemiology of human polyomaviruses". PLoS Pathogens. 5 (3): e1000363. doi:10.1371/journal.ppat.1000363. PMC 2655709. PMID 19325891. 22. Tolstov YL, Pastrana DV, Feng H, et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. International Journal of Cancer 2009; 125 (6): 1250-1256.